about
Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasiaExploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens.Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy.Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells.PTEN, more than the AKT pathway.The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.Genetic modelling of the PTEN/AKT pathway in cancer research.Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinasesMouse models to decipher the PI3K signaling network in human cancer.Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.Nucleotide sequence of the genes encoding the subunits H, B, A' and A'' of the DNA-dependent RNA polymerase and the initiator tRNA from Thermoplasma acidophilum.Identification of transcripts specific for physiological gene activation by platelet-derived growth factor (PDGF)-B in intact brain tissue.Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration.Correction: Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia.Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia.Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancerThe expression of constitutively active isotypes of protein kinase C to investigate preconditioning
P50
Q28485913-57539AD2-BD20-4A58-9903-E2C2EA3A517DQ33533301-6177A0D8-CAFD-4B3C-A25A-FF2E133DA529Q33646972-8CBEC95B-0F29-45D9-81B5-FC10CFB0DBA9Q34309108-B300D10B-6807-4009-9DE9-05338ABD07C3Q35791370-42ADAD24-7C6D-45F8-8666-A76F9204F59CQ36753139-3FF43D1B-55F3-4637-8E91-9276D273CBA8Q37160617-4D6CE54B-B96B-49EF-A756-4AD8C3011D08Q37305035-26C9EA5A-6226-45C3-A0A4-EEA0F51866CAQ37460004-9DF89334-80A1-412F-8EAB-4674A633D008Q37550767-23AECA19-A759-4FFC-924E-024F71BD8269Q38303558-1F42782D-7F39-494D-8DE3-DAB0885E2D41Q39910389-48779A06-07A1-4E4D-AD8E-A6BBB6BCADDCQ40534694-1BAC67A2-61EF-413D-BAEF-A3606693DE2FQ42815740-7308D415-4890-4B76-BB49-7C1EC2B0119DQ44911153-CE9CBD03-1CB1-4A6C-899B-7DD18C665E89Q45788487-2D8B4DAB-342B-4CA5-B161-62F111277674Q46469133-3800D26F-89B2-4ED0-8F82-BD77CF50A0DEQ48308816-103B4AEE-B355-4B36-B146-1CEC5A37F722Q53337645-213E6A5A-9593-4405-BB11-EB6000D96697Q57975488-840BDF1E-7A0F-45C2-BD60-2A75266BC82CQ77172045-D364FD2B-8691-4E51-8E83-EE386D449D06
P50
description
researcher, ORCID id # 0000-0002-4046-0517
@en
wetenschapper
@nl
name
Oliver Renner
@ast
Oliver Renner
@en
Oliver Renner
@es
Oliver Renner
@nl
type
label
Oliver Renner
@ast
Oliver Renner
@en
Oliver Renner
@es
Oliver Renner
@nl
prefLabel
Oliver Renner
@ast
Oliver Renner
@en
Oliver Renner
@es
Oliver Renner
@nl
P106
P31
P496
0000-0002-4046-0517